The comparable prognostic and predictive role of TP53 mutations in TP53mutbas and TP53mutconv ALK+ NSCLC suggest a similar adverse biology in these tumours, regardless of the time-point and context of TP53 mutation detection. The gene discussed is ALK; the disease is neoplasm.